title: Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.
abstract: We describe here a protocol for labelling autologous white blood cells with (111)In-oxine based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.
authors.affiliation: Radiopharmacy Unit, Nuclear Medicine Department, Hospital Universitario de Bellvitge, Barcelona, Spain.
authors.forename: Manel
authors.initials: M
authors.lastname: Roca
authors.forename: Erik F J
authors.initials: EF
authors.lastname: de Vries
authors.forename: Francois
authors.initials: F
authors.lastname: Jamar
authors.forename: Ora
authors.initials: O
authors.lastname: Israel
authors.forename: Alberto
authors.initials: A
authors.lastname: Signore
mesh_terms: D000328:Adult; D002469:Cell Separation / Q000379:methods; D002634:Chemotaxis, Leukocyte; D002675:Child, Preschool; D006801:Humans; D007205:Indium Radioisotopes / Q000493:pharmacokinetics; D007239:Infections / Q000000981:diagnostic imaging; D007249:Inflammation / Q000000981:diagnostic imaging; D007553:Isotope Labeling / Q000379:methods*; D007962:Leukocytes; D009942:Organometallic Compounds / Q000493:pharmacokinetics; D015125:Oxyquinoline / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D011835:Radiation Protection / Q000331:legislation & jurisprudence / Q000379:methods; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014018:Tissue Distribution
chemical_list: D007205:Indium Radioisotopes; D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; C032950:indium oxine; D015125:Oxyquinoline